2. Academic Validation
  3. Discovery of small-molecule inhibitors of the TLR1/TLR2 complex

Discovery of small-molecule inhibitors of the TLR1/TLR2 complex

  • Angew Chem Int Ed Engl. 2012 Dec 3;51(49):12246-9. doi: 10.1002/anie.201204910.
Kui Cheng 1,  Xiaohui Wang,  Shuting Zhang,  Hang Yin
Affiliations

Affiliation

  • 1 Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.
PMID: 22969053 DOI: 10.1002/anie.201204910
Abstract

The protein complex of Toll-like Receptor 1 and 2 (TLR1/2) is an important regulator of innate immunity, and therefore provides an attractive target for the treatment of various immune disordres. Here we report a novel compound (CU-CPT22) that can compete with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 with high inhibitory activity and specificity. Repression of downstream signaling from TNF-α and IL-1β has also been observed.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z